At a 5 mg / 1 mL reconstitution (5 mg/mL common from research vendors who use less BAC water), divide each volume by 2.5: 250 g becomes 0.05 mL, 500 g becomes 0.10 mL
Christensen B, Gibson PR, Micic D et al
The largest research base of any peptide in the Durham Peptides catalog
Explore more peptide therapy options at Iowa IV here
Designed for advanced peptide research environments, AOD 9604 is commonly studied in metabolic and receptor-related research models where precision and purity are essential
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials